Dec 12 (Reuters) - GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory ...

Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...

The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

There is underreporting of adverse effects from vaccines; but, in the vast majority of cases, the side effects from the ...

You are correct that there is underreporting of adverse effects from vaccines; however, in the vast majority of cases, the ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory syncytial virus (RSV) vaccine reduced RSV infections and RSV-related ...

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus ...

A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

An agency memo alleged that at least 10 children died after receiving coronavirus vaccinations, citing it as a basis for overhauling how vaccines are approved, despite studies finding the shots have ...

According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...

The Food and Drug Administration is investigating whether Covid-19 vaccines caused deaths in adults, as part of a safety ...